Open AccessUse of Paclitaxel Coated Drug Eluting Technology to Improve Central Vein Patency for Haemodialysis Access Circuits: Any Benefit?
Author(s) -
Tze Tec Chong,
Hao Yun Yap,
Chieh Suai Tan,
Shaun Qw Lee,
Sze Ling Chan,
Ian Jun Yan Wee,
Tjun Yip Tang
Publication year - 2020
Publication title -
vascular specialist international
Language(s) - English
Resource type - Journals
eISSN - 2288-7989
pISSN - 2288-7970
DOI - 10.5758/vsi.2020.36.1.21
Subject(s) - medicine , angioplasty , stenosis , interquartile range , surgery , hemodialysis , vein , dialysis , balloon , retrospective cohort study
Central venous stenosis is a recurring problem affecting dialysis access patency. Increasing evidence suggests that the use of drug-coated balloons (DCBs) improves target lesion primary patency (TLPP) in dialysis access. However, few studies have investigated the use of DCBs specifically in central venous stenosis. Thus, this study presents our initial experience with DCBs in the central vein of a dialysis access circuit.